{
    "pmid": "41459844",
    "title": "Precision Medicine and Artificial Intelligence in Next-Generation Cancer Surgery: A Comprehensive Analysis of Clinical Applications, Therapeutic Outcomes, and Implementation Strategies.",
    "abstract": "Cancer surgery is undergoing transformative integration of precision medicine, artificial intelligence (AI), robotics, advanced imaging, and molecular technologies. These innovations promise enhanced surgical precision, improved patient outcomes, and personalized treatment approaches through data-driven decision-making. A comprehensive systematic literature review was conducted across PubMed, Embase, Cochrane Library, and Web of Science databases from January 2020 to November 2025. Studies were analyzed for clinical applications, therapeutic outcomes, cost-effectiveness, and implementation challenges. Primary endpoints included surgical accuracy, margin status, survival outcomes, complication rates, and technology adoption metrics. Precision medicine utilizing genomic profiling and circulating tumor DNA demonstrated 94.9% sensitivity and 88.8% specificity in multi-cancer detection. The CIRCULATE-Japan GALAXY study showed ctDNA positivity during the molecular residual disease window predicted significantly inferior disease-free survival (HR 11.99; P < 0.0001) and overall survival (HR 9.68; P < 0.0001). AI-assisted surgical systems achieved area under the curve values of 0.76-0.85 in outcome prediction and reduced surgical complications by 25-30%. The da Vinci 5 robotic system demonstrated 43% reduction in tissue damage through force feedback technology. Meta-analysis of 15,137 patients showed robotic pancreatoduodenectomy reduced hospital stays and conversion rates compared to laparoscopy. Fluorescence-guided surgery achieved improved 5-year overall survival (80.6% vs. 66.7%, P = 0.018) in gastric cancer. Mass spectrometry techniques achieved 93.4-97.1% diagnostic accuracy. Perioperative immunotherapy in non-small cell lung cancer reduced recurrence risk by 43% (HR 0.57) and improved pathological complete response rates over 5-fold (RR 5.58). Nanotechnology-based delivery systems reduced cardiac toxicity (6% vs. 21%) while maintaining therapeutic efficacy. The convergence of precision medicine, AI, robotics, and molecular technologies is revolutionizing cancer surgery toward personalized, data-driven interventions with substantial clinical outcome improvements. Implementation challenges including cost, standardization, and healthcare disparities require systematic addressing for widespread adoption.",
    "disease": "breast cancer",
    "clean_text": "precision medicine and artificial intelligence in next generation cancer surgery a comprehensive analysis of clinical applications therapeutic outcomes and implementation strategies cancer surgery is undergoing transformative integration of precision medicine artificial intelligence ai robotics advanced imaging and molecular technologies these innovations promise enhanced surgical precision improved patient outcomes and personalized treatment approaches through data driven decision making a comprehensive systematic literature review was conducted across pubmed embase cochrane library and web of science databases from january to november studies were analyzed for clinical applications therapeutic outcomes cost effectiveness and implementation challenges primary endpoints included surgical accuracy margin status survival outcomes complication rates and technology adoption metrics precision medicine utilizing genomic profiling and circulating tumor dna demonstrated sensitivity and specificity in multi cancer detection the circulate japan galaxy study showed ctdna positivity during the molecular residual disease window predicted significantly inferior disease free survival hr p and overall survival hr p ai assisted surgical systems achieved area under the curve values of in outcome prediction and reduced surgical complications by the da vinci robotic system demonstrated reduction in tissue damage through force feedback technology meta analysis of patients showed robotic pancreatoduodenectomy reduced hospital stays and conversion rates compared to laparoscopy fluorescence guided surgery achieved improved year overall survival vs p in gastric cancer mass spectrometry techniques achieved diagnostic accuracy perioperative immunotherapy in non small cell lung cancer reduced recurrence risk by hr and improved pathological complete response rates over fold rr nanotechnology based delivery systems reduced cardiac toxicity vs while maintaining therapeutic efficacy the convergence of precision medicine ai robotics and molecular technologies is revolutionizing cancer surgery toward personalized data driven interventions with substantial clinical outcome improvements implementation challenges including cost standardization and healthcare disparities require systematic addressing for widespread adoption"
}